CrossRef SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells Wufei Ye, Tao Chen, Yueran Li, Jiajie Luan, Kui Yang, Sheng Wang Acta Biochimica et Biophysica Sinica .2026;[Epub] CrossRef Celastrol delays the progression of hepatocellular carcinoma by suppressing SLC1A5-mediated glutamine dependence Simeng Xiao, Yun Zhao, Zhiguo Chen, Yangkun Xiong, Dingmei Zhang, Gang Zhou, Cong Zhang Toxicology and Applied Pharmacology .2026
Probably not directly but it might increase your risk if you get dehydrated or do not eat a healthy, balanced diet
There are medications that work, but theyre priced for profits, not patients. Indeed, obesity is a pervasive health issue, and not just in the U.S
Some patients may notice appetite, digestion, or eating-pattern changes earlier, while weight-related progress may take longer and depends on eligibility, dosing, lifestyle habits, and provider monitoring
While prescribers are pharmacists rather than doctors, they specialise in weight management and follow national safety standards for GLP-1 care
